Who
John R. Haines
Senior Exec Vice President
Company insider
Files Form 4 as: Senior Exec Vice President, Celularity.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jul 2021
- Last trade
- 13 Apr 2026
- Last filed
- 15 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code M | —1,641 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $746583 at $1.28 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,641 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,641 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code M | —1,641 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $746583 at $1.28 | filing |
| 13 Apr 2025filed 15 Apr 2025 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,641 at $0.00 | filing |
| 13 Apr 2025filed 15 Apr 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code M | —1,641 at $0.00 | filing |
| 13 Apr 2025filed 15 Apr 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $946577 at $1.64 | filing |
| 17 Feb 2025filed 19 Feb 2025 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Feb 2025filed 19 Feb 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
| 17 Feb 2025filed 19 Feb 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $15K7,035 at $2.14 | filing |
| 13 Apr 2024filed 16 Apr 2024 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $2,367576 at $4.11 | filing |
| 17 Feb 2024filed 21 Feb 2024 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $30K70,350 at $0.43 | filing |
| 16 Feb 2024filed 21 Feb 2024 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —216,014 at $0.00 | filing |
| 13 Apr 2023filed 17 Apr 2023 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $4,0975,770 at $0.71 | filing |
| 17 Feb 2023filed 22 Feb 2023 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —400,000 | filing |
| 13 Apr 2022filed 28 Apr 2022 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —192,401 at $0.00 | filing |
| 13 Apr 2022filed 28 Apr 2022 | CELU CelularityBiotechnology | SEC FORM 4 Code A | —65,617 | filing |
| 9 Sep 2021filed 13 Sep 2021 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code A | —384,297 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.